Merck (MRK)

• Market cap: $240B
• 1 day: 1.46%
• 5 days: 0.48%
• 1 month: 12.19%
• 3 months: -7.15%
• 6 months: -18.25%
• Year to date: -4.50%
• 1 year: -22.47%
• 5 years: 23.40%
• 10 years: 68.52%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

69% more first-time investments, than exits

New positions opened: 349 | Existing positions closed: 206

15% more call options, than puts

Call options by funds: $1.8B | Put options by funds: $1.56B

2% more funds holding

Funds holding: 3,438 [Q3] → 3,498 (+60) [Q4]

1.02% more ownership

Funds ownership: 76.65% [Q3] → 77.68% (+1.02%) [Q4]

11% less capital invested

Capital invested by funds: $221B [Q3] → $196B (-$24.3B) [Q4]

17% less repeat investments, than reductions

Existing positions increased: 1,290 | Existing positions reduced: 1,549

36% less funds holding in top 10

Funds holding in top 10: 111 [Q3] → 71 (-40) [Q4]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $96 1% upside
• Avg. target: $111 17% upside
• High target: $120 27% upside

9 analyst ratings

• positive: 5 56%
• neutral: 4 44%
• negative: 0 0%

Deutsche Bank James Shin 40% 1-year accuracy 2 / 5 met price target	11% upside $105	Hold Downgraded	18 Feb 2025
Guggenheim Vamil Divan 48% 1-year accuracy 12 / 25 met price target	21% upside $115	Buy Maintained	12 Feb 2025
B of A Securities Tim Anderson 46% 1-year accuracy 6 / 13 met price target	18% upside $112	Buy Maintained	5 Feb 2025
BMO Capital Evan David Seigerman 37% 1-year accuracy 7 / 19 met price target	1% upside $96	Market Perform Maintained	5 Feb 2025
Citigroup Andrew Baum 67% 1-year accuracy 4 / 6 met price target	21% upside $115	Buy Maintained	5 Feb 2025